A High-Risk, High-Reward Approach to ALS
Multidisciplinary group of U-M researchers will investigate environmental exposures, chosen as one of the first projects in a new NIH amyotrophic lateral sclerosis initiative.
Multidisciplinary group of U-M researchers will investigate environmental exposures, chosen as one of the first projects in a new NIH amyotrophic lateral sclerosis initiative.
Tiffany Braley, M.D., M.S. , an associate professor of neurology at University of Michigan Health, was surprised when a patient she was caring for explained why they needed to go home from the hospital as soon as possible: their pets.
University of Michigan (U-M) clinician-researchers, led by Roger Albin, MD, Anne B. Young Collegiate Professor of Neurology, Co-Director, U-M Movement Disorders Division, and Director, U-M Parkinson’s Foundation Research Center of Excellence, were awarded a five-year $11.7 million grant from the National Institute of Neurological Diseases and
Principal investigators Tiffany Braley MD, MS and Galit Levi Dunietz PhD, MPH were recently awarded $1.4M in new R01 funding by the National Institute on Aging to study unexplored pathways between obstructive sleep apnea (OSA), OSA treatment, and dementia risk in older women and men.
Principal investigators Tiffany Braley MD, MS (Neurology) and Anna Kratz PhD (Physical Medicine and Rehabilitation) were recently awarded $3.3M in new R01 funding from the National Center for Complimentary and Integrative Health to conduct research on the effects of cannabinoids on sleep and pain in people with MS.
The Michigan Alzheimer’s Disease Research Center received continued funding from the National Institutes of Health to continue its work across the state of Michigan for five more years.
More information can be found on their website
Dr. Roger Albin interviews with Crain's Detroit Business about Parkinson's Disease and its possible relation to viral infections.
Subscription may be required for full access.
Ann Arbor, MI – The work of affiliates of the Michigan Alzheimer’s Disease Research Center captured the attention of the Journal of Biological Chemistry last week for their new findings which could change the trajectory of treatment for key neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and
ANN ARBOR, Mich. — Michigan Medicine’s adult hospitals were ranked best in Michigan and 11th in the nation by U.S. News & World Report “Best Hospitals” rankings for 2021-2022. This prestigious honor measures excellence in patient care.
The American Neurological Association (ANA) , the professional organization representing the world’s top academic neurologists and neuroscientists, has announced the recipients of its 2021 scientific awards, to be presented during the 146th ANA Annual Meeting , which will be
If you know you need more sleep —or better sleep—and aren't quite sure how to make it happen, it's time to talk about pre-sleep habits that might help. Busy schedules and busy brains cut into precious sleep time, whether it’s a conscious decision or not, which is why so
Having trouble sleeping? You're not alone. Sleep disorders have grown so prevalent since the start of the pandemic, there's a name for it — "coronasomnia."
As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer’s disease approved in 18 years, patients want to know: “Will this medication help me — and how much?”
Amid the COVID-19 pandemic, many neurologic clerkships underwent changes in format. Here, clerkship directors and professors of neurology share how training might evolve as a result and what the student experience was like in clinic.
Data from clinical trials of three experimental Alzheimer’s disease drugs expected to start emerging next year could help shed light on whether U.S. regulators were justified in their controversial approval of a Biogen Inc
2021 University of Michigan Neurology and Neurosurgery Neuroscience Day Winners:
If you’re having trouble falling asleep, problems remembering or concentrating are likely to occur more than a decade later, according to new University of Michigan research.
Norman Mayer, 86, walks around with a computer chip in his chest and doesn't think a thing about it.
Deep brain stimulation remained effective in Parkinson's disease patients more than 15 years after the device was implanted, and patients continued to demonstrate significant improvement in motor symptoms, a retrospective study showed.
Alzheimer’s disease impacts roughly 5 million Americans, a number that is expected to grow as our population ages over the next three decades.